Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT> ?p ?o ?g. }
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "in 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management" provenance.
- OBJECT label "Aminopeptidase N activity in a dose-and time-dependent manner" provenance.
- OBJECT label "Aminopeptidase N activity in a dose-and time-dependent manner" provenance.
- OBJECT label "Aminopeptidase N activity in a dose-and time-dependent manner" provenance.
- OBJECT label "Aminopeptidase N activity in a dose-and time-dependent manner" provenance.
- OBJECT label "Aminopeptidase N activity in a dose-and time-dependent manner" provenance.
- OBJECT label "Aminopeptidase N activity in a dose-and time-dependent manner" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "with usual care in patients not requiring oxygen supplementation , leading to a NNH value of 26.7 ( 95%CI 18.1–50.9 , p < 0.05 )" provenance.
- OBJECT label "both tumor necrosis factor" provenance.
- OBJECT label "both tumor necrosis factor" provenance.
- OBJECT label "to be an effective treatment in the subgroup of patients requiring oxygen supplementation" provenance.
- OBJECT label "to be an effective treatment in the subgroup of patients requiring oxygen supplementation" provenance.
- OBJECT label "to be an effective treatment in the subgroup of patients requiring oxygen supplementation" provenance.
- OBJECT label "to be an effective treatment in the subgroup of patients requiring oxygen supplementation" provenance.
- OBJECT label "to be an effective treatment in the subgroup of patients requiring oxygen supplementation" provenance.
- OBJECT label "to be an effective treatment in the subgroup of patients requiring oxygen supplementation" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "exogenous BID expression and the antitumor effect of a promoter system ( TTS ) that we designed that is specifically targeted to lung cancer cells but which does not affect other types of cells including stem cells both in vitro and in vivo" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "remarkable efficacyparticularly for COVID-19 patients who underwent mechanical ventilation" provenance.
- OBJECT label "to reduce maternal mortality, can" provenance.